0001641172-25-011513.txt : 20250519 0001641172-25-011513.hdr.sgml : 20250519 20250519171935 ACCESSION NUMBER: 0001641172-25-011513 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250519 DATE AS OF CHANGE: 20250519 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Immix Biopharma, Inc. CENTRAL INDEX KEY: 0001873835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 454869378 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41159 FILM NUMBER: 25965109 BUSINESS ADDRESS: STREET 1: 11400 WEST OLYMPIC BLVD. STREET 2: SUITE 200 CITY: LOS ANGELES STATE: CA ZIP: 90064 BUSINESS PHONE: (888) 958-1084 MAIL ADDRESS: STREET 1: 10573 W. PICO BLVD. STREET 2: #58 CITY: LOS ANGELES STATE: CA ZIP: 90064 10-K/A 1 form10-ka.htm 10-K/A
true FY 0001873835 0001873835 2024-01-01 2024-12-31 0001873835 2024-06-30 0001873835 2025-03-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K/A

(Amendment No. 1)

 

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2024

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to _________

 

Commission file number 001-41159

 

IMMIX BIOPHARMA, INC.

(Exact name of registrant as specified in charter)

 

Delaware   45-4869378

(State or jurisdiction of

Incorporation or organization)

  

I.R.S. Employer

Identification No.

 

11400 West Olympic Blvd., Suite 200, Los Angeles, CA   90064
(Address of principal executive offices)   (Zip code)

 

(310) 651-8041

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, $0.0001 par value   IMMX   The Nasdaq Stock Market LLC

 

Securities registered pursuant to Section 12(g) of the Act: None.

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐   Accelerated filer ☐
Non-accelerated filer ☒   Smaller reporting company ☒
      Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant as of the last business day of the registrant’s most recently completed second fiscal quarter ended June 30, 2024 was $32,432,613 based upon the closing price of the registrant’s common stock of $1.98 on The Nasdaq Capital Market as of that date. Further information concerning shareholdings of our officers, directors and principal stockholders is included or incorporated by reference in Part III, Item 12 of this Annual Report on Form 10-K.

 

Number of common shares outstanding as of March 11, 2025 was 27,722,108 shares.

 

Documents Incorporated by Reference: None.

 

 

 

 

 

 

Explanatory Note

 

On March 25, 2025, Immix Biopharma, Inc. filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “Original Form 10-K”) with the U.S. Securities and Exchange Commission (the “SEC”). The Original Form 10-K failed to include certain required inline XBRL tagging which was inadvertently omitted in the Original Form 10-K, and this Amendment No. 1 to Annual Report on Form 10-K (“Amendment No. 1”) is being filed solely to include such inline XBRL tagging under Item 1C. Cybersecurity.

 

As such, this Amendment No. 1:

 

  ● restates Part I, Item 1C (Cybersecurity), of the Original Form 10-K to include the required XBRL tagging; and
     
  ● files new certifications of our principal executive officer and principal financial officer as exhibits to this Amendment under Item 15 of Part IV hereof, pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

 

This Amendment No. 1 does not otherwise change or update any of the disclosures set forth in the Original Form 10-K, and, except as expressly stated herein, does not reflect events occurring after the filing of the Original Form 10-K.

 

 

 

 

TABLE OF CONTENTS

 

PART I  
Item 1C. Cybersecurity 1
   
PART IV  
Item 15. Exhibits and Financial Statement Schedules 2

 

i

 

 

PART I

 

ITEM 1C. CYBERSECURITY

 

Risk Management and Strategy. We employ processes for assessing, identifying, and managing material risks from cybersecurity threats that are incorporated into our overall risk management system. These items are designed to help protect our information assets from internal and external threats and protect the integrity and confidentiality of our data. Our system includes procedural and technical safeguards, response plans, and reviews of our policies. We engage various external entities, including consultants, to improve and enhance our cybersecurity oversight. We provide all employees and consultants with cybersecurity and prevention training including timely and relevant topics covering social engineering, phishing, mobile security, and data protection and the need for reporting incidents and suspicious events immediately. With respect to third parties that assist in our cybersecurity oversight, we obtain reports to assess the security of their systems and processes. We engage in ongoing monitoring of all third-party providers to ensure compliance with our cybersecurity standards.

 

Although we develop and maintain systems and controls designed to prevent cybersecurity threats from occurring, and we have a process to identify and mitigate threats, the development and maintenance of these systems, controls and processes is costly and requires ongoing monitoring and updating as technologies change and efforts to overcome security measures become increasingly sophisticated. Moreover, despite our efforts, the possibility of these events occurring cannot be eliminated entirely. As we outsource more of our information systems to vendors, engage in more electronic transactions with service providers and patients, and rely more on cloud-based information systems, the related security risks will increase and we will need to expend additional resources to protect our technology and information systems. In addition, there can be no assurance that our internal information technology systems or those of our third-party contractors, or our consultants’ efforts to implement adequate security and control measures, will be sufficient to protect us against breakdowns, service disruption, data deterioration or loss in the event of a system malfunction, or prevent data from being stolen or corrupted in the event of a cyberattack, security breach, industrial espionage attacks or insider threat attacks which could result in financial, legal, business or reputational harm.

 

As of the date of this report, we are not aware of any risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, that have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations, or financial condition.

 

Governance. Our senior management team conducts the regular assessment and management of material risks from cybersecurity threats, including review with our IT team and third-party service providers. All employees and consultants are directed to report to our senior management any irregular or suspicious activity that could indicate a cybersecurity threat or incident. The Audit Committee of our Board of Directors evaluates our cybersecurity assessment and management policies, including quarterly interviews with our senior officers and independent registered accounting firm.

 

1

 

 

PART IV

 

ITEM 15. EXHIBITS, FINANCIAL STATEMENTS AND SCHEDULES

 

(a)

 

No financial statement or supplemental data are filed with this Amendment No. 1 to Form 10-K. See Index to Financial Statements and Supplemental Data of the Original Form 10-K.

 

(b) Exhibits

 

The exhibits required to be filed by Item 15 are set forth in, and filed with or incorporated by reference in, the “Exhibit Index” of the Original Form 10-K. The attached list of exhibits in the “Exhibit Index” sets forth the additional exhibits required to be filed with this Amendment No. 1 and is incorporated herein by reference in response to this item.

 

Exhibit

Number 

   Description
     
31.3*   Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act
31.4*   Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act
101.INS   Inline XBRL Instance Document (filed herewith)
101.SCH   Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents (filed herewith)
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

*Filed herewith.

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Immix Biopharma, Inc.
   
Date: May 19, 2025   /s/ Ilya Rachman
  By: 

Ilya Rachman,
    Chief Executive Officer
    (Principal Executive Officer)

  

3

 

 EX-31.3 2 ex31-3.htm EX-31.3

 

EXHIBIT 31.3

 

Certification of Chief Executive Officer

 

I, Ilya Rachman, certify that:

 

1. I have reviewed this Annual Report on Form 10-K/A of Immix Biopharma, Inc. (the “registrant”); and
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

Date: May 19, 2025  
   
/s/ Ilya Rachman  
Ilya Rachman  

Chief Executive Officer

(Principal Executive Officer)

  

  

 

 EX-31.4 3 ex31-4.htm EX-31.4

 

EXHIBIT 31.4

 

Certification of Principal Financial Officer

 

I, Gabriel Morris, certify that:

 

1. I have reviewed this Annual Report on Form 10-K/A of Immix Biopharma, Inc. (the “registrant”); and
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

Date: May 19, 2025  
   
/s/ Gabriel Morris  
Gabriel Morris  

Chief Financial Officer

(Principal Financial/Accounting Officer)

  

  

 

 

 EX-101.SCH 4 immx-20241231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 5 immx-20241231_def.xml XBRL DEFINITION FILE EX-101.LAB 6 immx-20241231_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Cybersecurity Risk Management, Strategy, and Governance [Abstract] Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Cybersecurity Risk Management Processes Integrated [Flag] Cybersecurity Risk Management Processes Integrated [Text Block] Cybersecurity Risk Management Third Party Engaged [Flag] Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Cybersecurity Risk Board of Directors Oversight [Text Block] Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Role of Management [Text Block] Cybersecurity Risk Management Positions or Committees Responsible [Flag] Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Material Cybersecurity Incident [Abstract] Material Cybersecurity Incident Nature [Text Block] Material Cybersecurity Incident Scope [Text Block] Material Cybersecurity Incident Timing [Text Block] Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block] Material Cybersecurity Incident Information Not Available or Undetermined [Text Block] EX-101.PRE 7 immx-20241231_pre.xml XBRL PRESENTATION FILE XML 9 R1.htm IDEA: XBRL DOCUMENT v3.25.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2024
Mar. 11, 2025
Jun. 30, 2024
Cover [Abstract]      
Document Type 10-K/A    
Amendment Flag true    
Amendment Description On March 25, 2025, Immix Biopharma, Inc. filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “Original Form 10-K”) with the U.S. Securities and Exchange Commission (the “SEC”). The Original Form 10-K failed to include certain required inline XBRL tagging which was inadvertently omitted in the Original Form 10-K, and this Amendment No. 1 to Annual Report on Form 10-K (“Amendment No. 1”) is being filed solely to include such inline XBRL tagging under Item 1C. Cybersecurity.  As such, this Amendment No. 1:     ● restates Part I, Item 1C (Cybersecurity), of the Original Form 10-K to include the required XBRL tagging; and         ● files new certifications of our principal executive officer and principal financial officer as exhibits to this Amendment under Item 15 of Part IV hereof, pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).   This Amendment No. 1 does not otherwise change or update any of the disclosures set forth in the Original Form 10-K, and, except as expressly stated herein, does not reflect events occurring after the filing of the Original Form 10-K.      
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2024    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2024    
Current Fiscal Year End Date --12-31    
Entity File Number 001-41159    
Entity Registrant Name IMMIX BIOPHARMA, INC.    
Entity Central Index Key 0001873835    
Entity Tax Identification Number 45-4869378    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 11400 West Olympic Blvd.    
Entity Address, Address Line Two  Suite 200    
Entity Address, City or Town  Los Angeles    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 90064    
City Area Code (310)    
Local Phone Number 651-8041    
Title of 12(b) Security Common stock, $0.0001 par value    
Trading Symbol IMMX    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Elected Not To Use the Extended Transition Period false    
Entity Shell Company false    
Entity Public Float     $ 32,432,613
Entity Common Stock, Shares Outstanding   27,722,108  
Documents Incorporated by Reference [Text Block] None    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
XML 10 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Cybersecurity Risk Management and Strategy Disclosure
 12 Months Ended
Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Abstract]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Risk Management and Strategy. We employ processes for assessing, identifying, and managing material risks from cybersecurity threats that are incorporated into our overall risk management system. These items are designed to help protect our information assets from internal and external threats and protect the integrity and confidentiality of our data. Our system includes procedural and technical safeguards, response plans, and reviews of our policies. We engage various external entities, including consultants, to improve and enhance our cybersecurity oversight. We provide all employees and consultants with cybersecurity and prevention training including timely and relevant topics covering social engineering, phishing, mobile security, and data protection and the need for reporting incidents and suspicious events immediately. With respect to third parties that assist in our cybersecurity oversight, we obtain reports to assess the security of their systems and processes. We engage in ongoing monitoring of all third-party providers to ensure compliance with our cybersecurity standards.

 

Although we develop and maintain systems and controls designed to prevent cybersecurity threats from occurring, and we have a process to identify and mitigate threats, the development and maintenance of these systems, controls and processes is costly and requires ongoing monitoring and updating as technologies change and efforts to overcome security measures become increasingly sophisticated. Moreover, despite our efforts, the possibility of these events occurring cannot be eliminated entirely. As we outsource more of our information systems to vendors, engage in more electronic transactions with service providers and patients, and rely more on cloud-based information systems, the related security risks will increase and we will need to expend additional resources to protect our technology and information systems. In addition, there can be no assurance that our internal information technology systems or those of our third-party contractors, or our consultants’ efforts to implement adequate security and control measures, will be sufficient to protect us against breakdowns, service disruption, data deterioration or loss in the event of a system malfunction, or prevent data from being stolen or corrupted in the event of a cyberattack, security breach, industrial espionage attacks or insider threat attacks which could result in financial, legal, business or reputational harm.

 

As of the date of this report, we are not aware of any risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, that have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations, or financial condition.

 
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] As of the date of this report, we are not aware of any risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, that have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations, or financial condition.
Cybersecurity Risk Board of Directors Oversight [Text Block] Governance. Our senior management team conducts the regular assessment and management of material risks from cybersecurity threats, including review with our IT team and third-party service providers. All employees and consultants are directed to report to our senior management any irregular or suspicious activity that could indicate a cybersecurity threat or incident. The Audit Committee of our Board of Directors evaluates our cybersecurity assessment and management policies, including quarterly interviews with our senior officers and independent registered accounting firm.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Our senior management team conducts the regular assessment and management of material risks from cybersecurity threats, including review with our IT team and third-party service providers.
Cybersecurity Risk Management Positions or Committees Responsible [Text Block] The Audit Committee of our Board of Directors evaluates our cybersecurity assessment and management policies, including quarterly interviews with our senior officers and independent registered accounting firm.
XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.25.1 html 3 46 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://immixbio.com/role/Cover Cover Cover 1 false false R2.htm 995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure Sheet http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure Cybersecurity Risk Management and Strategy Disclosure Notes 2 false false All Reports Book All Reports form10-ka.htm immx-20241231.xsd immx-20241231_def.xml immx-20241231_lab.xml immx-20241231_pre.xml http://xbrl.sec.gov/cyd/2024 http://xbrl.sec.gov/dei/2024 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-ka.htm": { "nsprefix": "IMMX", "nsuri": "http://immixbio.com/20241231", "dts": { "inline": { "local": [ "form10-ka.htm" ] }, "schema": { "local": [ "immx-20241231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "definitionLink": { "local": [ "immx-20241231_def.xml" ] }, "labelLink": { "local": [ "immx-20241231_lab.xml" ] }, "presentationLink": { "local": [ "immx-20241231_pre.xml" ] } }, "keyStandard": 46, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2024": 3 }, "contextCount": 3, "entityCount": 1, "segmentCount": 0, "elementCount": 81, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 38, "http://xbrl.sec.gov/cyd/2024": 8 }, "report": { "R1": { "role": "http://immixbio.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-ka.htm", "first": true, "unique": true } }, "R2": { "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure", "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure", "shortName": "Cybersecurity Risk Management and Strategy Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "2", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-ka.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r23" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r23" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]" } } }, "auth_ref": [ "r20", "r36" ] }, "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]" } } }, "auth_ref": [ "r20", "r36" ] }, "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]" } } }, "auth_ref": [ "r22", "r38" ] }, "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]" } } }, "auth_ref": [ "r22", "r38" ] }, "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]" } } }, "auth_ref": [ "r15", "r31" ] }, "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementProcessesIntegratedFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes Integrated [Flag]" } } }, "auth_ref": [ "r16", "r32" ] }, "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes Integrated [Text Block]" } } }, "auth_ref": [ "r16", "r32" ] }, "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract", "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]" } } }, "auth_ref": [ "r14", "r30" ] }, "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Third Party Engaged [Flag]" } } }, "auth_ref": [ "r17", "r33" ] }, "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]" } } }, "auth_ref": [ "r19", "r35" ] }, "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]" } } }, "auth_ref": [ "r19", "r35" ] }, "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]" } } }, "auth_ref": [ "r20", "r36" ] }, "cyd_CybersecurityRiskRoleOfManagementTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskRoleOfManagementTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Role of Management [Text Block]" } } }, "auth_ref": [ "r21", "r37" ] }, "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]" } } }, "auth_ref": [ "r18", "r34" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r23" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r11", "r13", "r23", "r29" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r28" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r42" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r39" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r23" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r40" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r11", "r13", "r23" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "cyd_MaterialCybersecurityIncidentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentAbstract", "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident [Abstract]" } } }, "auth_ref": [ "r24", "r25" ] }, "cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]" } } }, "auth_ref": [ "r24", "r26" ] }, "cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]" } } }, "auth_ref": [ "r24", "r27" ] }, "cyd_MaterialCybersecurityIncidentNatureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentNatureTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Nature [Text Block]" } } }, "auth_ref": [ "r24", "r27" ] }, "cyd_MaterialCybersecurityIncidentScopeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentScopeTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Scope [Text Block]" } } }, "auth_ref": [ "r24", "r27" ] }, "cyd_MaterialCybersecurityIncidentTimingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentTimingTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Timing [Text Block]" } } }, "auth_ref": [ "r24", "r27" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://immixbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r41" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "i" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "ii" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "iii" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "2" }, "r20": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "1" }, "r21": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "2" }, "r22": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "2", "Subparagraph": "i" }, "r23": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r24": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 6-K", "Section": "General Instruction", "Subsection": "B" }, "r25": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Section": "1.05" }, "r26": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Section": "1.05", "Subsection": "Instruction", "Paragraph": "2" }, "r27": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Section": "1.05", "Subsection": "a" }, "r28": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r29": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r30": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106" }, "r31": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1" }, "r32": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "i" }, "r33": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "ii" }, "r34": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "iii" }, "r35": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "2" }, "r36": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "1" }, "r37": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "2" }, "r38": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "2", "Subparagraph": "i" }, "r39": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r40": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r41": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r42": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 17 0001641172-25-011513-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001641172-25-011513-xbrl.zip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end XML 18 form10-ka_htm.xml IDEA: XBRL DOCUMENT 0001873835 2024-01-01 2024-12-31 0001873835 2024-06-30 0001873835 2025-03-11 iso4217:USD shares iso4217:USD shares true FY 0001873835 10-K/A true 2024-12-31 --12-31 2024 false 001-41159 IMMIX BIOPHARMA, INC. DE 45-4869378 11400 West Olympic Blvd.  Suite 200  Los Angeles CA 90064 (310) 651-8041 Common stock, $0.0001 par value IMMX NASDAQ No No Yes Yes Non-accelerated Filer true true false false false false 32432613 27722108 None On March 25, 2025, Immix Biopharma, Inc. filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “Original Form 10-K”) with the U.S. Securities and Exchange Commission (the “SEC”). The Original Form 10-K failed to include certain required inline XBRL tagging which was inadvertently omitted in the Original Form 10-K, and this Amendment No. 1 to Annual Report on Form 10-K (“Amendment No. 1”) is being filed solely to include such inline XBRL tagging under Item 1C. Cybersecurity.  As such, this Amendment No. 1:     ● restates Part I, Item 1C (Cybersecurity), of the Original Form 10-K to include the required XBRL tagging; and         ● files new certifications of our principal executive officer and principal financial officer as exhibits to this Amendment under Item 15 of Part IV hereof, pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).   This Amendment No. 1 does not otherwise change or update any of the disclosures set forth in the Original Form 10-K, and, except as expressly stated herein, does not reflect events occurring after the filing of the Original Form 10-K.   <i>Risk Management and Strategy</i>. We employ processes for assessing, identifying, and managing material risks from cybersecurity threats that are incorporated into our overall risk management system. These items are designed to help protect our information assets from internal and external threats and protect the integrity and confidentiality of our data. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240101__20241231_zdhe7UIpka5g">Our system includes procedural and technical safeguards, response plans, and reviews of our policies. We engage various external entities, including consultants, to improve and enhance our cybersecurity oversight.</span> We provide all employees and consultants with cybersecurity and prevention training including timely and relevant topics covering social engineering, phishing, mobile security, and data protection and the need for reporting incidents and suspicious events immediately. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240101__20241231_zi4b8HFcQb1h">With respect to third parties that assist in our cybersecurity oversight, we obtain reports to assess the security of their systems and processes.</span> We engage in ongoing monitoring of all third-party providers to ensure compliance with our cybersecurity standards.<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we develop and maintain systems and controls designed to prevent cybersecurity threats from occurring, and we have a process to identify and mitigate threats, the development and maintenance of these systems, controls and processes is costly and requires ongoing monitoring and updating as technologies change and efforts to overcome security measures become increasingly sophisticated. Moreover, despite our efforts, the possibility of these events occurring cannot be eliminated entirely. As we outsource more of our information systems to vendors, engage in more electronic transactions with service providers and patients, and rely more on cloud-based information systems, the related security risks will increase and we will need to expend additional resources to protect our technology and information systems. In addition, there can be no assurance that our internal information technology systems or those of our third-party contractors, or our consultants’ efforts to implement adequate security and control measures, will be sufficient to protect us against breakdowns, service disruption, data deterioration or loss in the event of a system malfunction, or prevent data from being stolen or corrupted in the event of a cyberattack, security breach, industrial espionage attacks or insider threat attacks which could result in financial, legal, business or reputational harm.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_98D_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_c20240101__20241231_zmbDqsXohioc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this report, we are <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240101__20241231_zMylksTwLBQa">not</span> aware of any risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, that have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations, or financial condition.</p>   true true As of the date of this report, we are <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240101__20241231_zMylksTwLBQa">not</span> aware of any risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, that have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations, or financial condition. false <i>Governance</i>. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90D_ecyd--CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20240101__20241231_zifb6UYxXu9d">Our senior management team conducts the regular assessment and management of material risks from cybersecurity threats, including review with our IT team and third-party service providers.</span> All employees and consultants are directed to report to our senior management any irregular or suspicious activity that could indicate a cybersecurity threat or incident. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_902_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_c20240101__20241231_zX3N4vVBUPd4">The Audit Committee of our Board of Directors evaluates our cybersecurity assessment and management policies, including quarterly interviews with our senior officers and independent registered accounting firm.</span> Our senior management team conducts the regular assessment and management of material risks from cybersecurity threats, including review with our IT team and third-party service providers. The Audit Committee of our Board of Directors evaluates our cybersecurity assessment and management policies, including quarterly interviews with our senior officers and independent registered accounting firm.